AUTHORS
Bret Jensen
With over 20 years of experience in the financial industry, Bret Jensen brings success as an investor and entrepreneur to TheStreet Real Money Pro team. As the chief investment strategist at Simplified Asset Management between 2008-2011, Jensen’s small long/short hedge fund was in the top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database. He currently acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management.
Jensen specializes in value and GARP investing, along with simple options strategies like covered call trades. He is passionate about teaching others how to achieve financial independence at a relatively young age like he did.
He has been a Real Money and Real Money Pro contributor for TheStreet team since 2012. His coverage focuses primarily on sector coverage, stock trading ideas, options trading, and macroeconomic trends. Fun fact about Jensen: he became a professional poker player at the age of 18 before turning his attention to investing.
Recent Articles By The Author
I'm Placing Bets on a Couple of Giants to Lose Ground in the Coming Months
This pair of household names easily could pull back based on the economic challenges ahead.
The Word Is, 'Lexicon' Is Worth a Trade
Here's an options play on this small pharma name that just scored an FDA win.
'Sticky Inflation' Isn't Going to Be Unstuck Anytime Soon
And the likelihood that inflation will be persistent should keep interest rates higher for longer, which will have multiple negative economic consequences.
Finding Value in a 'Unique' Niche of the Healthcare Sector
Insider buying by the new CEO of this buyer of biopharmaceutical royalties, puts this name on my radar.
I See a Way to Make Some Bread Off of Toast Inc.
Here's an options play on this software company for the restaurant industry.
Stocks Are Climbing a 'Wall of Worry'
I'm constantly looking for opportunities in this overvalued market.
These Small-Cap Biotech Stocks Have the Wind at Their Back
After getting a 'win' earlier this week on an acquisition, let's highlight a few similar names in my portfolio.
We'll See if I'm the Sucker at the Table in the Second Half of 2023
I'm betting the economy and equities will deteriorate in the back half of the year as a weakening consumer and interest rate pressures take their toll.
This Option Play Should Make Some 'Bread'
Let's look at this Ohio-based financial services name -- with credit partners that include Victoria's Secret -- and why the bad news should be priced in already.
2 Small-Cap Stocks That Are Making Significant Progress
For now they're to be considered speculative.
Oops!
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Please Join or Log In to Email Our Authors.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login